This inventor holds 3 USPTO granted patents and 4 published patent applications and 3 EPO patents. Top assignee: Chugai Seiyaku Kabushiki Kaisha. Active years: 2012-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012-2016
Title: Yasuharu Kato: Innovator in ALK Inhibitor Compounds
Introduction
Yasuharu Kato, an esteemed inventor based in Shizuoka, Japan, has made significant contributions to the field of medicinal chemistry. With a remarkable portfolio that includes three patents, Kato's work primarily focuses on developing compounds that serve as inhibitors for specific targets in cancer therapy and cognitive disorders.
Latest Patents
Among Yasuharu Kato's latest innovations are the patents for a tetracyclic compound, represented by the general formula (I). This compound, or its salts and solvates, has demonstrated potential as an ALK inhibitor. It is particularly useful for the prophylaxis or treatment of diseases associated with abnormalities in ALK, including cancer, cancer metastasis, depression, and cognitive function disorders. His patents reflect a dedication to addressing critical health challenges through innovative solutions.
Career Highlights
Throughout his career, Yasuharu Kato has shown a commitment to advancing pharmaceutical sciences. His role at Chugai Seiyaku (Chugai Pharmaceutical Co., Ltd.) has provided him with the opportunity to work on groundbreaking research and development projects. Kato's expertise has significantly contributed to the company's mission of developing treatment options that improve patient outcomes.
Collaborations
Yasuharu Kato's journey in innovation is further enriched through his collaborations with talented coworkers such as Kazutomo Kinoshita and Kohsuke Asoh. Working alongside fellow researchers, Kato has been able to share insights and drive novel approaches to medicinal compounds. Together, they foster an environment of creativity and scientific exploration.
Conclusion
In conclusion, Yasuharu Kato stands out as a prominent inventor whose work in ALK inhibitors is paving the way for advancements in treatment against various diseases. His contributions through patents not only showcase his inventive spirit but also reflect the collaborative effort within Chugai Seiyaku. As he continues to push the boundaries of scientific innovation, Kato's influence will likely resonate throughout the medical field for years to come.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile